"Biopure corporation case analysis" Essays and Research Papers

Sort By:
Satisfactory Essays
Good Essays
Better Essays
Powerful Essays
Best Essays
Page 1 of 50 - About 500 Essays
  • Satisfactory Essays

    Biopure Corporation

    • 431 Words
    • 2 Pages

    Course: Biopure Corporation 1. Decision: Biopure should launch Oxyglobin at a price of $200 immediately in the market. The early introduction of Oxyglobin may jeopardize the ability to set a high price for Hemopure‚ but the benefits of introduction will outweigh the risks. 2. Recommendation: Biopure should price Oxyglobin at $200 per unit. At the same time‚ it should enlarge the production capacity as soon as possible to satisfy the potential market demand for Hempure. As for the distribution

    Premium Blood Blood transfusion

    • 431 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Decision Sheet – Biopure Corporation Marketing Objective – Whether to launch Oxyglobin now or delay it till the approval of Hemopure. If yes‚ then devise a marketing plan for Oxyglobin. Options – 1. Launch Oxyglobin in the market immediately. 2. Defer the launch of Oxyglobin now till Hemopure release. Recommendation – Biopure Corporation should immediately launch Oxyglobin priced at $200. Rationale – Applying SWOT Analysis to the situation: Strengths 1. FDA approval has already come

    Premium Blood Blood transfusion Marketing

    • 599 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Executive Summary Biopure Corporation was established in 1984 and is a privately owned pharmaceutical firm. They are trying to launch two new products: Hemopure (human market) and Oxyglobin (veterinary market). They are the only company aggressively engaged in the development of blood substitutes for the vet market. Biopure has invested $200M in the development of said blood substitutes. They currently don’t have any revenues with little to no debt and financing of $50M to support these operations

    Premium Health care Net present value Medicine

    • 513 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure case analysis

    • 611 Words
    • 3 Pages

    Carl Rausch FROM: RE: Biopure Market Analysis DATE: Oct 31‚ 2013 Deciding whether to go into the veterinary blood market now or not is a critical decision to Biopure right now. To maximize the profits and capture the valuable opportunity‚ Biopure is recommended to step into the marketplace and be the first to offer Oxyglobin‚ blood substitute for the animal market. Pioneering the veterinary blood market is expected to generate gross profits of $26.55 miilion to Biopure annually‚ with a breakeven

    Premium Blood transfusion Blood

    • 611 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure Case Analysis

    • 1200 Words
    • 5 Pages

    Brief Overview: Biopure has two new products namely Oxyglobin and Hemopure. Oxyglobin is a first of its kind‚ new blood substitute for the veterinary market and has passed all the tests and is ready for consumer use. Hemopure is another such blood substitute for the human market and it will take a minimum of two years to launch the product from now. There is a concern about creating an unrealistic price expectation for Hemopure by marketing Oxyglobin before Hemopure. Whereas another point of view

    Free Blood Blood transfusion

    • 1200 Words
    • 5 Pages
    Satisfactory Essays
  • Good Essays

    Biopure Case

    • 7016 Words
    • 29 Pages

    scenarios of Biopure’s products launching and provides marketing plan of the recommended one. The study shows that Biopure should immediately launch Oxyglobin rather than wait for Hemopure’s FDA Approval then launch both products simultaneously. The proposed price for Oxyglobin is $300 per unit with promotion campaign from time to time. With this set price of immediate launch‚ Biopure will reach breakeven point for Oxyglobin in year 2000 with the amount of 2.13 million USD. Targeting market for Oxyglobin

    Free Blood Blood transfusion

    • 7016 Words
    • 29 Pages
    Good Essays
  • Good Essays

    Biopure Case

    • 1372 Words
    • 6 Pages

    Biopure Corporation: Case Write-Up Problem Definition In February 1998 Biopure Corporation faced a difficult decision regarding the launch of its newly developed “blood substitute” products. Biopure had developed “Hemopure”‚ a blood substitute for humans‚ and an ancillary product “Oxyglobin” for the veterinary market1. Hemopure was still in the process of gaining Federal Drug Administration (FDA) approval ‚ while Oxyglobin had already been approved and was ready to be launched1. FDA approval was

    Premium Blood Blood transfusion Pricing

    • 1372 Words
    • 6 Pages
    Good Essays
  • Better Essays

    Biopure Case

    • 1638 Words
    • 7 Pages

    BioPure Corporation‚ which was founded in 1984 by entrepreneurs Carl Rausch and David Judelson‚ is a privately owned biopharmaceutical firm specializing in the ultra purification of proteins for human and veterinary use. In 1998 Biopure pioneered the development of oxygen therapeutics using "Hemoglobin"‚ a new class of pharmaceuticals that are intravenously administered to deliver oxygen to the body’s tissues. Biopure’s two products‚ Hemopure for human use‚ and Oxyglobin for animal veterinary use

    Free Blood Blood transfusion Blood bank

    • 1638 Words
    • 7 Pages
    Better Essays
  • Satisfactory Essays

    + Biopure Corporation Case Analysis Back Bay Xue Yang + Agenda 1. Current Situation 2. SWOT Analysis 3. Quantitative Analysis 4. Recommendations + Current SituationBiopure Corporation  The main objectives of Biopure Corporation is blood substitutes development  There are 2 products: Oxyglobin and Hemopure. Oxyglobin is targeting at veterinary market and Hemopure is targeting at human market  The company has spent $200 million on R&D of Hemopure  Oxyglobin has already approved

    Premium Variable cost Blood Marketing

    • 906 Words
    • 14 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure Case: Questions

    • 1807 Words
    • 10 Pages

    Sep 19 Student Name: Miao Wang Net ID: mxw142330 Case Study 1 Biopure Case Questions: 1. Hemopure: a. Identify relevant market segments and speculate whether the product is valuable to each segment at the suggested prices ($600-$800) As the case said the Biopure in human market‚ sometime the Hemopure could be $600-$800 per unit‚ which is very higher price than the Oxyglobin. This high price product which relevant market segments should be taken this price level ‚ following the attach Exhibit

    Free Blood Red blood cell Blood transfusion

    • 1807 Words
    • 10 Pages
    Satisfactory Essays
Previous
Page 1 2 3 4 5 6 7 8 9 50